Rydar Equities’s Bristol-Myers Squibb BMY Stock Holding History

Rydar Equities’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$60.1K	Buy	+1,007	New	+$63.6K	0.03%	171

Other funds holding BMY

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

PensionDanmark Copenhagen O, Denmark $12.3B AUM 33.99% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Rydar Equities's BMY Position: Q3 2026 in Review

Rydar Equities opened a new position in Bristol-Myers Squibb (BMY) in Q3 2026: 1,007 shares worth $60.1K. The stake represents 0.03% of the portfolio and ranks #171 among its holdings.

474 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

Rydar Equities held 1,007 shares of Bristol-Myers Squibb worth $60.1K as of Q3 2026.
Bristol-Myers Squibb was a new Rydar Equities position in Q3 2026.
Bristol-Myers Squibb made up 0.03% of Rydar Equities's portfolio in Q3 2026, its #171 holding.
474 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Rydar Equities's 13F filing for Q3 2026, filed 13 Oct 2026.